USP Issues Change to Viscosity Reference in Monographs - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

USP Issues Change to Viscosity Reference in Monographs


ePT--the Electronic Newsletter of Pharmaceutical Technology

The United States Pharmacopeia (USP) has stated that references to General Chapter <911> “Viscosity” will be changed to General Chapter <911> “Viscosity—Capillary Viscometer Methods,” <912> “Rotational Rheometer Methods,” or <913> “Rolling Ball Viscometer Method.” Seventy monographs will be affected.

The changes reflect a modernized General Chapter <911> and two new proposed General Chapters <912> and <913> published in Pharmacopeia Forum 37(4) and 37(5) in 2011 and approved by the General Chapters—Physical Analysis Expert Committee.

The changes will become official Dec. 1, 2012, and will be reflected in the Second Supplement to USP 35–NF 30. A list of impacted monographs can be found on the USP website.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: ePT--the Electronic Newsletter of Pharmaceutical Technology,
Click here